 The drug tested in this study is called bortezomib VELCADE. VELCADE was tested in people who have Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma. This study looked at the efficacy of RCHOP rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone with or without VELCADE. 